Quantcast Royal Purple
College Media Network

Gardasil: A shot in the right direction

Kassie Lechner

Issue date: 10/15/08 Section: Lifestyle
  • Print
  • Email
Media Credit: Alison Wisneski

The newest advancement in cervical cancer prevention is the vaccination Gardasil, and if given the recommended way, can protect against four types of HPV (human papilomavirus).

Gardasil not only protects against certain types of cervical cancer, but it also helps protect against other diseases caused by four strains of HPV. The vaccine is given to girls and young women ages 9 to 26, and is most effective if given before being sexually active, according to the Center for Disease Control (CDC).

"This particular product helps protect against four strains of high risk HPV," Forrest Bright, Family Nurse Practitioner for University Health and Counseling Services, said. "When we say high risk, what we mean is that these viruses have been associated with cervical cancer."

The vaccine is currently being offered at the Ambrose Health Center at $135 per shot, and is given in a series of three shots. The period in which the shots are given is usually six months, with the second shot being given after two months from the first shot, and the third shot after six months, according to the CDC. The shot is usually administered in the upper arm.

"The shot itself doesn't hurt," Alexandra Haroldson, sophomore, said. "It's just like a normal shot. The needle is actually shorter than a normal needle."

Despite some negative feedback of the vaccine causing miscarriages, paralysis and even death, the CDC continues to label the vaccine as being safe and effective, according to their website.

Haroldson said she thinks the shot should be required on campuses.

"I do believe that campuses should make it mandatory," Haroldson said. "I think that it's a smart thing for girls to do. I know there are drawbacks like paralysis, but the risks are so minimal that it would be worth it to get the shot to prevent anything from happening."

Judicial Watch, a public interest group, has been studying the adverse effects of Gardasil. Gardasil went on the market in June 2006, so it is still in the testing phase and final reports of the vaccine won't be made until September 2009, according to a special report on the Judicial Watch Web site. According to an article on the Natural News Web site, Judicial Watch has gathered reports of "21 deaths and 9,749 adverse reactions," but there has been no evidence to directly link the vaccine to the deaths and some of the reactions.
Page 1 of 2 next >

Article Tools

Be the first to comment on this story

  • NOTE: Email address will not be published

Type your comment below (html not allowed)

  I understand posting spam or other comments that are unrelated to this article will cause my comment to be flagged for deletion and possibly cause my IP address to be permanently banned from this server.

Advertisement

Poll

What benefits do you think UW-Whitewater will gain from the new online voting?
Submit Vote

View Results

Advertisement

Sections

Options

Links